Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.
-
Monico LB, Bambury EA, Foreman JK, Avila M, Martin SA. Retention in Telehealth-Delivered Buprenorphine Treatment for Opioid Use Disorder: Multistate Retrospective Cohort Study. J Med Internet Res. 2026 08 14; 28:e100527.
-
Patel KS, Bovell-Ammon B, Van Siclen R, Miller W, Zellmer L, Fu SS, Chamberlain AM, Drawz PE, Rossom R, Wilhelm A, Winkelman TNA. Comparison of statewide substance use disorder prevalence estimates from survey data vs electronic health record data. Drug Alcohol Depend. 2026 Oct 01; 287:113313.
-
Paudel K, Gautam K, Pagoto S, Xu R, Wickersham JA, Altice FL, Bhusal S, Sujan MSH, Copenhaver M, Hong C, Shrestha R. Suicidal ideation, mental health services, and barriers to care among syringe services program clients who use opioids. PLoS One. 2026; 21(7):e0354745.
-
Hsu HE, Lodi S, Yan S, Bovell-Ammon BJ, Christine PJ, Tilhou AS, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment. JAMA Netw Open. 2026 07 01; 9(7):e2623280.
-
Gautam K, Paudel K, Wickersham JA, Khati A, Thapa A, Bhusal S, Sujan MSH, Pagoto S, Ha T, Shrestha R. Smartphone-Based Ecological Momentary Assessment to Monitor Opioid Use and Overdose Among People Who Use Opioids: Prospective Observational Feasibility Study. JMIR Hum Factors. 2026 06 29; 13:e95655.
-
Gorman JA, Ameral VE, Abrams BE, Park D, Kaubrys MM, Khazanov GK. Contingency management for adherence to injectable medication for substance use disorders. J Subst Use Addict Treat. 2026 Nov; 190:210055.
-
Bailey A, Kang AW, Martin RA. Advancing Opioid Use Disorder Treatment: A Narrative Review of Evidence-Based Solutions to Systems-Level Barriers in the US. Subst Use Addctn J. 2026 Oct; 47(4):1244-1256.
-
Stopka TJ, Rottapel RE, Ruggiro M, Santelices C, Friedmann PD, Pivovarova E, Evans EA. "So what's gonna happen when I get out of here?" Qualitative barriers and facilitators to MOUD continuity post-release from jail. Drug Alcohol Depend. 2026 Aug 01; 285:113227.
-
Fredericksen RJ, Sibley A, Lancaster KE, Jenkins W, Mixson LS, Whitney BM, Ouellet L, Friedmann PD, Korthuis T, Delaney JAC, Tsui JI, Crane HM, Zule W, Young AM, Seal DW, Stopka TJ. Transitions from first drug use to illicit opioid and injection drug use in a multisite rural U.S. cohort of people who use drugs. Harm Reduct J. 2026 05 02; 23(1).
-
Chan B, Ezekiel-Herrera D, Bailey SR, Byhoff E, Marino M, Lucas JA, Giebultowicz S, Espinoza K, Larson Z, Heintzman J. Race, Ethnicity, and Language Disparities in Alcohol and Drug Screening and Medication Treatment. JAMA Netw Open. 2026 05 01; 9(5):e2612319.